Top 100 Remote Patient Monitoring Companies Shaping Global Healthcare

A cardiologist reviewing overnight heart rhythm data from a patient’s connected device, a diabetes care team adjusting insulin guidance based on continuous glucose readings, and a hospital command center watching vital signs from patients recovering at home all depend on the same underlying shift. Healthcare is moving from episodic, in-person checkups toward continuous monitoring that fills the gaps between visits.

Remote patient monitoring, or RPM, spans a wide range of companies, from established medical device manufacturers to venture-backed software startups, all building some piece of this connected care infrastructure. This piece maps 100 companies across the categories that define the RPM market. It functions as a market map rather than an endorsement or a definitive competitive ranking.

Top 100 Remote Patient Monitoring Companies at a Glance

The single table below consolidates all companies covered in this market map into one combined view, with a category column so the list can still be scanned by market segment. Companies appearing in more than one functional area throughout the report are listed once here under their primary category.

This consolidated view spans established medical device manufacturers, digital health startups, and infrastructure providers, reflecting how broad the remote patient monitoring category has become. The category breakdowns below revisit these same companies with additional context on how each segment of the market functions.

How the 100 Companies Were Selected

Inclusion was based on active market presence, a meaningful and verifiable remote monitoring offering, relevance to healthcare delivery rather than pure consumer fitness tracking, technology differentiation, evidence of clinical or enterprise deployment, and geographic or category significance within the broader RPM landscape. Startups, established medical device manufacturers, and care delivery companies all appear side by side, reflecting how genuinely mixed this market’s competitive landscape has become.

The RPM Market in Six Technology Categories

Connected medical devices form the physical foundation of remote monitoring, ranging from blood pressure cuffs to continuous glucose monitors and cardiac patches.

Wearable biosensors extend monitoring into daily life, often collecting data passively without requiring the patient to take a specific measurement action.

Chronic disease monitoring platforms layer software and clinical workflow on top of device data, turning raw readings into something a care team can act on.

Hospital at home and acute monitoring systems support higher acuity patients receiving care outside a traditional hospital setting, requiring more robust escalation protocols than typical chronic care programs.

AI-enabled remote care companies apply machine learning to flag concerning trends in patient data before they become emergencies.

Clinical workflow and RPM software companies handle the operational backbone connecting devices, data, and care teams, often integrating directly with electronic health record systems.

The Companies to Watch Most Closely

A smaller group of companies has drawn particular attention for their pace of growth and clinical positioning. Biofourmis has built its platform around AI-driven detection of patient deterioration patterns, combining wearable sensors with clinical protocols across cardiology, oncology, and post-acute care use cases, and has expanded further through its merger with CopilotIQ. Huma, based in the United Kingdom, positions its platform around regulated remote monitoring software combined with AI-driven health data analysis, serving both research and direct care applications.

Cadence has focused specifically on chronic care management for older adults, using what it describes as a proactive care engine that analyzes incoming data in real time and flags emerging health risks for clinical teams between scheduled visits. Established medical device manufacturers including Philips, Medtronic, Dexcom, and iRhythm continue to anchor the device side of the market, often integrating their hardware with third-party software platforms rather than building every layer of the RPM stack independently.

Corporate consolidation has reshaped this market meaningfully in recent periods, including the merger of CopilotIQ and Biofourmis and the combination of Accuhealth and Signallamp Health under shared ownership. Anyone evaluating a vendor should verify current corporate structure and product roadmap commitments directly, since acquisitions can affect long-term platform support.

RPM Companies by Clinical Use Case

The Technology Stack Behind RPM

A functioning RPM program depends on several coordinated layers. Sensors and devices capture physiological data at the patient’s location. Connectivity, whether cellular, Bluetooth, or Wi-Fi based, transmits that data to a central platform. Patient applications provide an interface for patients to view their own data and communicate with care teams when needed.

Cloud infrastructure stores and processes incoming data at scale, while data integration connects that information with a patient’s broader medical record. Analytics layers interpret the raw data into clinically meaningful trends, and alert management systems determine which findings require immediate clinical attention versus routine review. Clinician dashboards present this information to care teams in an actionable format, and clinical escalation protocols define exactly what happens when a concerning trend or reading is detected.

What Makes an RPM Company Actually Valuable

A device alone does not constitute a successful RPM program. Device accuracy matters, but so does patient adherence, since a highly accurate device generates no clinical value if patients stop using it after a few weeks. Data quality depends on both device performance and how consistently a patient interacts with the monitoring system.

Interoperability with existing electronic health record systems determines whether monitoring data actually reaches the clinicians who need it, rather than sitting isolated in a separate platform. Alert burden, meaning how many notifications a care team receives and how many of those are clinically meaningful versus noise, directly affects whether a program is sustainable for clinical staff over time. Clinical workflow integration, security practices, published evidence supporting outcomes, and a viable reimbursement and business model round out what separates a genuinely valuable RPM company from one offering an interesting device with limited real-world clinical impact.

How Healthcare Organizations Should Evaluate RPM Vendors

A structured evaluation should start with the specific clinical use case a health system or practice is trying to address, since a platform built for post-acute cardiac monitoring is not automatically the right fit for a diabetes management program. Patient population characteristics, including technology comfort and connectivity access, should shape device selection alongside clinical requirements.

Integration capability with existing EHR and workflow systems deserves early evaluation, since retrofitting integration after a program launches tends to be far more disruptive than confirming compatibility upfront. Evidence of outcomes from existing client deployments, ongoing vendor support quality, total cost including devices and platform fees, current regulatory status, and the vendor’s ability to scale alongside program growth complete a thorough vendor evaluation process.

The remote patient monitoring market has evolved substantially from a collection of standalone connected devices into an increasingly integrated set of clinical care platforms, where sensors, data analytics, and human clinical judgment operate together rather than as separate, disconnected pieces. That integration, more than any single device’s technical specifications, is what continues to define which companies in this space deliver genuine clinical value.

FAQ

Q: What are the top remote patient monitoring companies?

A: Notable companies span device manufacturers like Medtronic, Dexcom, and Philips, alongside software and platform companies like Biofourmis, Huma, Cadence, and HealthArc, each serving different parts of the RPM ecosystem.

Q: What does an RPM company provide?

A: Depending on the company, offerings can include connected medical devices, monitoring software, clinical workflow tools, data analytics, and care team support services for managing patients remotely.

Q: Which companies offer remote monitoring for chronic diseases?

A: Companies including Cadence, HealthSnap, HealthArc, CareSimple, and Livongo focus specifically on chronic disease monitoring and care management programs.

Q: What devices are used in RPM?

A: Common devices include blood pressure cuffs, continuous glucose monitors, pulse oximeters, connected weight scales, and wearable biosensors that track vital signs continuously.

Q: How does RPM integrate with EHR systems?

A: Many RPM platforms use data integration tools to feed monitoring data directly into a patient’s electronic health record, allowing clinicians to review trends alongside other clinical information.

Q: Is remote patient monitoring covered by insurance?

A: Coverage varies by payer and specific billing codes used, and reimbursement policies for RPM services have evolved over time, so verifying current coverage with a specific insurer is recommended.

Q: What is the difference between RPM and telemedicine?

A: Telemedicine typically refers to a live or asynchronous clinical visit conducted remotely, while RPM involves continuous or periodic data collection from connected devices between visits.

Q: Which RPM companies use AI?

A: Companies including Biofourmis, Cadence, and Athelas incorporate AI to help detect concerning trends in patient data and prioritize which cases need clinical attention.

This article provides general information about remote patient monitoring companies and technologies and is not a substitute for professional medical advice. RPM technologies support clinical monitoring but do not independently replace professional healthcare evaluation and treatment.